STOCK TITAN

Reklaim Ltd. Announces Normal Course Issuer Bid to Protect Shareholder Value Amid Growing Demand for Consumer Data Privacy Solutions

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Reklaim (TSXV: MYID) (OTC: MYIDF) has announced a Normal Course Issuer Bid (NCIB) to repurchase up to 7,789,020 of its common shares, representing 10% of its public float. The NCIB, approved by the TSX Venture Exchange, will run from September 30th, 2024, to September 30th, 2025. Reklaim believes this move will protect shareholder value amid growing demand for consumer data privacy solutions.

The company, which allows consumers to view, edit, add, and option their data to brands for direct compensation, currently has 116,738,379 common shares issued and outstanding. Purchases will be made through the TSXV or alternative Canadian trading platforms at prevailing market prices, with Clarus Securities Inc. acting as the broker for the NCIB. All repurchased shares will be canceled and returned to the treasury.

Reklaim (TSXV: MYID) (OTC: MYIDF) ha annunciato un Offerta di Acquisto nel Corso Normale (NCIB) per riacquistare fino a 7.789.020 delle sue azioni ordinarie, che rappresentano il 10% della sua flottazione pubblica. L'NCIB, approvato dalla TSX Venture Exchange, sarà valido dal 30 settembre 2024 al 30 settembre 2025. Reklaim crede che questa mossa proteggerà il valore per gli azionisti in un contesto di crescente domanda di soluzioni per la privacy dei dati dei consumatori.

La società, che permette ai consumatori di visualizzare, modificare, aggiungere e opzionare i propri dati ai brand per un compenso diretto, attualmente ha 116.738.379 azioni ordinarie emesse e in circolazione. Gli acquisti saranno effettuati attraverso il TSXV o piattaforme di trading canadese alternative ai prezzi di mercato prevalenti, con Clarus Securities Inc. che agirà come broker per l'NCIB. Tutte le azioni riacquistate saranno annullate e restituite al tesoro.

Reklaim (TSXV: MYID) (OTC: MYIDF) ha anunciado una Oferta de Adquisición Normal (NCIB) para recomprar hasta 7.789.020 de sus acciones ordinarias, lo que representa el 10% de su flotación pública. La NCIB, aprobada por la TSX Venture Exchange, estará vigente desde 30 de septiembre de 2024 hasta el 30 de septiembre de 2025. Reklaim cree que este movimiento protegerá el valor de los accionistas en medio de la creciente demanda de soluciones para la privacidad de los datos de los consumidores.

La empresa, que permite a los consumidores ver, editar, agregar y optar sus datos para marcas a cambio de una compensación directa, actualmente tiene 116.738.379 acciones ordinarias emitidas y en circulación. Las compras se realizarán a través de TSXV o plataformas de trading canadienses alternativas a los precios de mercado vigentes, con Clarus Securities Inc. actuando como corredor para la NCIB. Todas las acciones recompradas serán canceladas y devueltas al tesoro.

Reklaim (TSXV: MYID) (OTC: MYIDF)는 정상적 발행자 매입 제안(NCIB)을 발표하여 최대 7,789,020주의 보통주를 재매입할 계획이며, 이는 공공 유동성의 10%에 해당합니다. TSX 벤처 거래소의 승인을 받은 NCIB는 2024년 9월 30일부터 2025년 9월 30일까지 유효합니다. Reklaim은 이 조치가 소비자 데이터 프라이버시 솔루션에 대한 증가하는 수요 속에서 주주 가치를 보호할 것이라고 믿고 있습니다.

회사는 소비자들이 자신의 데이터를 브랜드에 직접 보상받기 위해 조회, 수정, 추가 및 옵션을 부여할 수 있도록 하고 있으며, 현재 116,738,379주의 보통주가 발행되어 유통 중입니다. 매입은 현재 시장 가격으로 TSXV 또는 대안 캐나다 거래 플랫폼을 통해 이루어지며, Clarus Securities Inc.가 NCIB의 중개 역할을 합니다. 재매입된 모든 주식은 취소되고 재무제표로 반환됩니다.

Reklaim (TSXV: MYID) (OTC: MYIDF) a annoncé une Offre publique de rachat (NCIB) pour racheter jusqu'à 7 789 020 de ses actions ordinaires, représentant 10 % de sa flottation publique. Cette NCIB, approuvée par la TSX Venture Exchange, sera en vigueur du 30 septembre 2024 au 30 septembre 2025. Reklaim croit que cette initiative protégera la valeur des actionnaires face à une demande croissante pour des solutions de protection de la vie privée des données des consommateurs.

L'entreprise, qui permet aux consommateurs de visualiser, modifier, ajouter et proposer leurs données auprès des marques contre une compensation directe, a actuellement 116 738 379 actions ordinaires émises et en circulation. Les achats seront effectués via le TSXV ou des plateformes de trading canadiennes alternatives aux prix du marché en vigueur, avec Clarus Securities Inc. agissant comme courtier pour l'NCIB. Toutes les actions rachetées seront annulées et retournées au trésor.

Reklaim (TSXV: MYID) (OTC: MYIDF) hat ein Reguläres Übernahmeangebot (NCIB) angekündigt, um bis zu 7.789.020 seiner Stammaktien zurückzukaufen, was 10% des öffentlichen Streubesitzes entspricht. Das NCIB, genehmigt von der TSX Venture Exchange, läuft vom 30. September 2024 bis zum 30. September 2025. Reklaim ist der Ansicht, dass dieser Schritt den Wert für die Aktionäre inmitten der wachsenden Nachfrage nach Verbraucherdatenschutzlösungen schützen wird.

Das Unternehmen, das es den Verbrauchern ermöglicht, ihre Daten zu nutzen, zu bearbeiten, hinzuzufügen und den Marken gegen direkte Entschädigung anzubieten, hat derzeit 116.738.379 Stammaktien ausgegeben und im Umlauf. Die Käufe werden über die TSXV oder alternative kanadische Handelsplattformen zu den aktuellen Marktpreisen getätigt, wobei Clarus Securities Inc. als Broker für das NCIB fungiert. Alle zurückgekauften Aktien werden annulliert und an die Kasse zurückgegeben.

Positive
  • Implementation of Normal Course Issuer Bid (NCIB) to repurchase up to 7,789,020 common shares
  • NCIB aims to protect shareholder value and instill confidence in the company's future
  • Growing demand for consumer data privacy solutions indicates potential market opportunity
Negative
  • Company believes the market may not fully reflect the underlying value of its business, potentially indicating undervaluation

NEW YORK, Sept. 30, 2024 /PRNewswire/ - Reklaim Ltd., (TSXV: MYID) (OTC: MYIDF) ("Reklaim"), the destination where consumers can view, edit, add, and option their data to brands and platforms for direct compensation, announces it has received approval from the TSX Venture Exchange ("TSXV") to implement, at the Company's discretion, a normal course issuer bid ("NCIB") to purchase up to 7,789,020 of its common shares.

The Company is commencing the NCIB because it believes that the market may not always fully reflect the underlying value of the Company's business. The repurchase of its common shares at those times is deemed to be in the best interests of its shareholders, instilling confidence in the company's future.

The Company has 116,738,379 common shares issued and outstanding as of the date hereof. Under the NCIB, Reklaim may repurchase up to 10% of the number of Common Shares comprising its public float, which currently equals 7,789,020 common shares.

The NCIB will commence on September 30th, 2024, and continue until September 30th, 2025, or until the company has repurchased the maximum allowable number of common shares. Reklaim reserves the right to terminate the NCIB at any time. All shares purchased under this program will be canceled and returned to the treasury.

Purchases will be made through the TSXV or an alternative Canadian trading platform at prevailing market prices per the TSXV's policies. Due to its expertise and reputation in the market, the Company has engaged Clarus Securities Inc. to act as the broker for the NCIB.

Q2 CEO Letter:

Chapter 2, 2024

I often view these MD&A updates as chapters in a book, a narrative that unfolds over time. This 'book' has six sections, starting in 2019, each year containing four chapters (quarters). When we launched this company in the shell of its predecessor, Freckle, the world began to shelter in place as COVID-19 inflected. Starting a nascent business during that time was challenging. We really had no business being a public company at that stage, but with the world closed and capital non-existent, we decided to put our heads down and build the product. Read the full CEO-Q2 letter here: https://www.investors.reklaimyours.com/press/q2-2024-ceo-letter

About Reklaim

Reklaim is committed to navigating the evolving landscape of consumer data privacy. We provide compliant, zero-party data solutions to Fortune 500 brands, platforms, and data companies. Our platform empowers consumers to reclaim control over their data, enabling them to view and manage information collected with direct authorization. Moreover, users can be compensated for their data through a Reklaim account. Discover more about Reklaim at https://investors.reklaimyours.com.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this press release constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking statements are provided to assist the reader in understanding Reklaim's current expectations and plans (including the NCIB) relating to the future. Readers are cautioned that such statements may not be appropriate for other purposes. Investors are cautioned that there is no assurance that any acquisitions will be completed under the NCIB. Forward-looking information may relate to Reklaim's future outlook and anticipated events and may include statements regarding the financial position, business strategy, budgets, litigation, projected costs, capital expenditures, financial results, taxes, and plans and objectives of or involving Reklaim. Particularly, statements regarding future acquisitions, the availability of credit, performance, achievements, prospects, or opportunities for Reklaim or the industry in which it operates are forward-looking statements. In some cases, forward-looking information can be identified by terms such as "may," "might," "will," "could," "should," "would," "occur," "expect," "plan," "anticipate," "believe," "intend," "seek," "aim," "estimate," "target," "project," "predict," "forecast," "potential," "continue," "likely," "schedule," or the negative thereof or other similar expressions concerning matters that are not historical facts.

Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions, and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While management considers these assumptions reasonable based on currently available information, they may prove incorrect.

The forward-looking statements made in this press release are dated and relate only to events or information as of the date of this press release. Except as specifically required by law, Reklaim undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/reklaim-ltd-announces-normal-course-issuer-bid-to-protect-shareholder-value-amid-growing-demand-for-consumer-data-privacy-solutions-302262082.html

SOURCE Reklaim Ltd.

FAQ

What is the maximum number of shares Reklaim (MYIDF) can repurchase under the NCIB?

Reklaim (MYIDF) can repurchase up to 7,789,020 of its common shares under the Normal Course Issuer Bid (NCIB).

When does Reklaim's (MYIDF) Normal Course Issuer Bid (NCIB) start and end?

Reklaim's (MYIDF) Normal Course Issuer Bid (NCIB) starts on September 30th, 2024, and ends on September 30th, 2025.

What percentage of Reklaim's (MYIDF) public float does the NCIB represent?

The NCIB represents 10% of Reklaim's (MYIDF) public float, which currently equals 7,789,020 common shares.

Who is the broker for Reklaim's (MYIDF) Normal Course Issuer Bid?

Clarus Securities Inc. has been engaged as the broker for Reklaim's (MYIDF) Normal Course Issuer Bid.

REKLAIM LTD

OTC:MYIDF

MYIDF Rankings

MYIDF Latest News

MYIDF Stock Data

6.96M
85.89M
33.15%
Software - Application
Technology
Link
United States of America
Toronto